TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
IMM Stock 12 Month Forecast
There Are No Analyst Ratings for AU:IMM In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
IMM Financial Forecast
IMM Earnings Forecast
Next quarter’s earnings estimate for IMM is >-AU$0.01 with a range of -AU$0.01 to AU$0.00. The previous quarter’s EPS was -AU$0.03. IMM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IMM has Performed in-line its overall industry.
Next quarter’s earnings estimate for IMM is >-AU$0.01 with a range of -AU$0.01 to AU$0.00. The previous quarter’s EPS was -AU$0.03. IMM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year IMM has Performed in-line its overall industry.
IMM Sales Forecast
Next quarter’s sales forecast for IMM is AU$20.63M with a range of AU$5.33M to AU$28.40M. The previous quarter’s sales results were AU$4.08M. IMM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IMM has Performed in-line its overall industry.
Next quarter’s sales forecast for IMM is AU$20.63M with a range of AU$5.33M to AU$28.40M. The previous quarter’s sales results were AU$4.08M. IMM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year IMM has Performed in-line its overall industry.
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (Other OTC: PRRUF), Coya Therapeutics, Inc. (NASDAQ: COYA) and Rapport Therapeutics, Inc. (NASDAQ: RAPP)
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$1.5
Buy
2042.86%
Upside
Reiterated
12/18/25
Ord Minnett Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
Analysts Offer Insights on Healthcare Companies: Immutep Ltd (Other OTC: PRRUF), Coya Therapeutics, Inc. (NASDAQ: COYA) and Rapport Therapeutics, Inc. (NASDAQ: RAPP)
Unknown Analyst
Ord Minnett
Not Ranked
Ord Minnett
AU$1.5
Buy
2042.86%
Upside
Reiterated
12/18/25
Ord Minnett Sticks to Its Buy Rating for Immutep Ltd (PRRUF)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Copying Madeleine Williams's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +15.70% per trade.
Copying Google Biotechnology's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -15.00% per trade.
Copying Google Biotechnology's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -15.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
IMM Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
4
2
2
1
0
Buy
0
0
0
0
0
Hold
0
2
2
2
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
4
4
3
0
In the current month, IMM has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. IMM average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
IMM Stock Forecast FAQ
What is AU:IMM’s average 12-month price target, according to analysts?
Currently, no data Available
What is AU:IMM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for AU:IMM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Immutep Ltd a Buy, Sell or Hold?
Currently, no data Available
What is Immutep Ltd’s share price target?
Currently, no data Available
What do analysts say about Immutep Ltd?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Immutep Ltd?
To buy shares of AU:IMM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.